封面
市場調查報告書
商品編碼
1654002

硫辛酸市場規模、佔有率和成長分析(按產品類型、產品形式、分銷管道、應用和地區)-產業預測(2025-2032 年)

Alpha Lipoic Acid Market Size, Share, and Growth Analysis, By Product Type (R Alpha Lipoic Acid, S Alpha Lipoic Acid), By Product Form (Powder, Capsules), By Distribution Channel, By Application, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2023 年,硫辛酸市場規模將達到 9.103 億美元,從 2024 年的 9.6856 億美元成長到 2032 年的 15.9096 億美元,預測期內(2025-2032 年)的複合年成長率為 6.4%。

硫辛酸 (ALA) 因其在能量產生和防止氧化壓力方面具有眾多健康益處而受到世界各地歡迎。由於 ALA 是一種天然物質,因此可以從多種食物中獲取,也可以作為膳食補充劑服用。市場成長的動力來自消費者對天然補充劑的興趣日益濃厚、對更健康生活方式的追求以及新研究強調了 ALA 對各種健康狀況的有效性。 ALA 因其對皮膚健康的益處、潛在減少氧化壓力和支持葡萄糖代謝而聞名,它因具有脂溶性和水溶性抗氧化劑的雙重作用而脫穎而出。 ALA 有多種形式,包括液體、錠劑和膠囊,既可以作為獨立產品出售,也可以以多種成分組合配方出售,以針對特定的健康問題。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 次要和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024 年)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

硫辛酸市場規模(依產品類型和複合年成長率) (2025-2032)

  • 市場概況
  • R-硫辛酸
  • S-硫辛酸

硫辛酸市場規模(依產品類型和複合年成長率) (2025-2032)

  • 市場概況
  • 粉末
  • 膠囊
  • 藥片
  • 其他

硫辛酸市場規模(按分銷管道和複合年成長率) (2025-2032)

  • 市場概況
  • 直接銷售
  • 間接銷售
  • 超級市場
  • 百貨公司
  • 零售商
  • 其他

硫辛酸市場規模(按應用和複合年成長率) (2025-2032)

  • 市場概況
  • 營養補充品
  • 化妝品
  • 藥品
  • 其他

硫辛酸市場規模及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前 5 家公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採用的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024 年)
  • 主要企業簡介
    • 公司詳細資訊
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • NNB 營養公司 (美國)
  • Avanscure Lifesciences(印度)
  • 江蘇同和藥業有限公司 (中國)
  • 蘇州富士萊藥業有限公司 (中國)
  • Cachet Pharmaceuticals Pvt. Ltd.(印度)
  • Biocon 有限公司 (印度)
  • Woerwag Pharma GmbH & Co. KG(德國)
  • 同和(中國)
  • 現代汽車(中國)
  • 福仕來藥業(中國)
  • 麥德森(中國)
  • 泰科生物(中國)
  • 迪凱源科技(中國)
  • 浩翔生物(中國)
  • Infa集團(義大利)
  • Sudarshan Pharma(印度)
  • 優質補充劑製造公司(美國)
  • Supreem Pharmaceuticals Mysore Pvt. Ltd.(印度)
  • Valence Labs(印度)
  • 西安光遠生物科技(中國)

結論和建議

簡介目錄
Product Code: SQMIG35J2082

Alpha Lipoic Acid Market size was valued at USD 910.3 million in 2023 and is poised to grow from USD 968.56 million in 2024 to USD 1590.96 million by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

Alpha lipoic acid (ALA) is gaining global popularity due to its numerous health benefits, focusing on energy production and protection against oxidative stress. As a naturally occurring substance, ALA can be sourced from various foods or taken as a dietary supplement. The market's growth is fueled by increasing consumer interest in natural supplements, the pursuit of healthier lifestyles, and emerging research highlighting ALA's effectiveness in addressing various health conditions. Known for its skin health benefits, potential to lower oxidative stress, and support in glucose metabolism, ALA stands out due to its dual role as a fat- and water-soluble antioxidant. Available in diverse formats like liquids, tablets, and capsules, ALA is marketed both as a standalone product and within multi-ingredient formulas targeting specific health concerns.

Top-down and bottom-up approaches were used to estimate and validate the size of the Alpha Lipoic Acid market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Alpha Lipoic Acid Market Segments Analysis

Global Alpha Lipoic Acid Market is segmented by Product Type, Product Form, Distribution Channel, Application and region. Based on Product Type, the market is segmented into R Alpha Lipoic Acid and S Alpha Lipoic Acid. Based on Product Form, the market is segmented into Powder, Capsules, Tablets and Others. Based on Distribution Channel, the market is segmented into Direct sales, Indirect sales, Supermarkets, Departmental Stores, Retailers and Others. Based on Application, the market is segmented into Dietary Supplements, Cosmetics, Pharmaceuticals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Alpha Lipoic Acid Market

The alpha lipoic acid (ALA) market is significantly driven by its renowned antioxidant properties, which enable it to effectively identify and neutralize free radicals that may inflict cellular damage. As awareness about these beneficial qualities grows, there has been a notable increase in consumer demand for dietary supplements infused with alpha lipoic acid. Many consumers are actively seeking products that not only enhance overall health but also serve as a preventive measure against chronic diseases and help manage oxidative stress. This rising interest in ALA supplements reflects a broader trend toward health optimization and wellness-focused lifestyles.

Restraints in the Alpha Lipoic Acid Market

The alpha lipoic acid market faces significant restraints due to the limited awareness among consumers and healthcare professionals regarding its advantages and applications. This lack of knowledge hinders the recognition and uptake of ALA, preventing it from receiving the attention it warrants. To overcome this obstacle, it is essential to implement educational initiatives aimed at both patients and medical practitioners, focusing on the benefits of ALA and its proper usage. By addressing this information gap, the market could experience enhanced growth as more individuals become informed about the potential of alpha lipoic acid and its applications in health and wellness.

Market Trends of the Alpha Lipoic Acid Market

The Alpha Lipoic Acid (ALA) market is witnessing a significant upward trend driven by the rising demand for nutraceuticals and dietary supplements. As health awareness intensifies among consumers, there is an increasing inclination towards products that offer multifaceted health benefits, particularly in metabolic wellness and antioxidant support. ALA is celebrated for its antioxidant properties and its role in various health facets, prompting manufacturers to incorporate it into diverse functional foods and supplements. This growing consumer preference for health-enhancing products is propelling the ALA market forward, reflecting a broader trend towards preventive healthcare and holistic wellness solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Alpha Lipoic Acid Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • R Alpha Lipoic Acid
  • S Alpha Lipoic Acid

Global Alpha Lipoic Acid Market Size by Product Form & CAGR (2025-2032)

  • Market Overview
  • Powder
  • Capsules
  • Tablets
  • Others

Global Alpha Lipoic Acid Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Direct sales
  • Indirect sales
  • Supermarkets
  • Departmental Stores
  • Retailers
  • Others

Global Alpha Lipoic Acid Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Dietary Supplements
  • Cosmetics
  • Pharmaceuticals
  • Others

Global Alpha Lipoic Acid Market Size & CAGR (2025-2032)

  • North America (Product Type, Product Form, Distribution Channel, Application)
    • US
    • Canada
  • Europe (Product Type, Product Form, Distribution Channel, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Product Form, Distribution Channel, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Product Form, Distribution Channel, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Product Form, Distribution Channel, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • NNB Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avanscure Lifesciences (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jiangsu Tohope Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Suzhou Fushilai Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cachet Pharmaceuticals Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biocon Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Woerwag Pharma GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tonghe (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shyndec (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fushilai Pharmaceutical (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maidesen (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Taike Biological (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DKY Technology (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haoxiang Bio (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Infa Group (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sudarshan Pharma (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Superior Supplement Manufacturing (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Supreem Pharmaceuticals Mysore Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Valence Labs (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xian Tian Guangyuan Biotech (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations